facebookrssdk flag

RESEARCH

NIKKB RESEARCH UNIT

Towards 2022, NIKKB research will focus on developing customised treatment for the individual patient, research into how we can implement new knowledge in daily practice and understand the lifelong trajectory of musculoskeletal disease.

Focus

NIKKB'S RESEARCH STRATEGY 2018-2022

The Research Unit at NIKKB has formulated a strategy outlining the institute's research priorities for the period 2018-2022.

Download it here

Throughout 2018, chiropractors and physiotherapists have had the opportunity to become certified in the GLA:D® Back treatment method in a number of certification courses at the University of Southern Denmark. Now Professor Per Kjaer and his GLA:D® Back co-researchers have published an article documenting the development, theory and evidence behind the treatment programme. You can read the full article on the BMC Musculoskeletal Disorders website through the link below.

 

Clinical guidelines recommend patient education, advice about staying active and at work and exercise to help people with persistent or recurrent back pain self-manage their pain.

 

GLA:D® (Good Life with osteoArthritis In Denmark) for knees and hips is one way of implementing the recommendations. Approximately 36 000 patients are registered users of GLA:D® and many have experienced a pain reduction of approximately 27 %, improved function and reduced use of painkillers, and the number of people on sick leave because of knee and hip pain has decreased. The success of GLA:D® led to a request for a similar treatment programme for back pain. GLA:D® Back is based on GLA:D®; the point of departure is the same and the researchers present a thorough documentation of the development of GLA:D® Back in the current paper.

 

The paper is divided into four sections. Section one describes the rationale behind GLA:D® Back, section 2 describes the objectives of the treatment, section 3 is about the programme design and the underlying theory and evidence, while section 4 gives you an overview of the final content of the treatment programme.

 

GLA:D® Back is a unique programme for group treatment due to the close integration of patient education and exercise. Furthermore, it is a generic treatment package, which can be implemented into various health systems. It is based on the best available evidence for treatment of people with persistent or recurrent back pain and all the educational, exercise and cognitive approaches have been evaluated in numerous clinical tests and have been found to be effective.

 

The GLA:D® approaches to treating knees, hips and backs has also caught the eyes of other countries. GLA:D® has already been implemented in Canada, Australia and China and the plan is to introduce GLA:D® Back in Canada in the near future.

 

GLA:D® Back group-based patient education integrated with exercises to support self-management of back pain - development, theories and scientific evidence. Per Kjaer, Alice Kongsted, Inge Ris, Allan Abbott, Charlotte Diana Nørregaard Rasmussen, Ewa M. Roos, Søren T. Skou, Tonny Elmose Andersen and Jan Hartvigsen. BMC Musculoskeletal Disorders 2018  https://doi.org/10.1186/s12891-018-2334-x